Coprocessed Excipients for Solid Dosage Forms

Bansal,Arvind;

Coprocessed Excipients for Solid Dosage Forms

January 2, 2004

By Arvind K. Bansal

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-01-02-2004

Volume 28

Issue 1

The authors examine the development and performance of coprocessed excipients, including testing them for flowability, compressibility, amd dilution potential.

External Link - article-81434.pdf

Articles in this issue

Coprocessed Excipients for Solid Dosage Forms

Manufacturing Execution Systems

State-of-the-Art Packaging Machines

January 2004

Medicare Bill Contains Significant Changes for Drug Manufacturers

The Bioterrorism Act

Establishing and Maintaining an Effective Gas Evaluation and Management Program

New Supply-Chain Dynamics

In the Spotlight--February 2004

January 2004

Related Content

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney

June 30th 2025

Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

3D Rendering of CAR - Chimeric Antigen Receptor Between T-Cell and Cancer Cell | Image Credit: © Alpha Tauri 3D - stock.adobe.com

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

Patrick Lavery

June 26th 2025

Article

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024

Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.